HG-030

N/A

Report date: 2025/11/13 16:00:04

NME

Base Information

Drug NameHG-030

Drug Alias NameHG-030

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionNeurotrophic tyrosine kinase receptor type 2 inhibitorsNeurotrophic tyrosine kinase receptor type 3 inhibitorsNerve growth factor receptor Trk-A antagonists +[5]

TargetsNeurotrophic tyrosine kinase receptor type 3Nerve growth factor receptor Trk-ANeurotrophic tyrosine kinase receptor type 2 +[5]

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesHitgen Inc

China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesHitgen Inc

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A